Literature DB >> 25898890

[Sexually transmitted infections of the anorectal region].

P Spornraft-Ragaller1, U Boashie, S Esser.   

Abstract

BACKGROUND: Sexually transmitted infections (STIs) are increasingly observed in men who have sex with men (MSM), which is associated with the success in the antiretroviral treatment of HIV infection. Additionally, in heterosexuals, anal intercourse is more prevalent than previously assumed. Thus, anorectal manifestations of STIs are not a rare condition.
OBJECTIVES: This review will focus on the clinical picture, diagnosis and therapy of frequent STIs involving the anorectal region.
CONCLUSIONS: Due to localisation and frequent asymptomatic course, STIs in this region often pose diagnostic problems. Anorectal manifestations of STIs consist of tumorous masses, ulcers or proctitis and may be misdiagnosed as malignancy or inflammatory bowel disease. Herpes simplex and syphilis primarily show ulcerations and may involve the perianal region, whereas gonorrhoea and lymphogranuloma venereum mainly cause proctitic symptoms with exsudation. Because of commonly occurring coinfections a complete diagnostic workup concerning other STIs should be performed.

Entities:  

Mesh:

Year:  2015        PMID: 25898890     DOI: 10.1007/s00105-015-3627-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  35 in total

Review 1.  ABC of colorectal diseases. Sexually transmitted diseases and anal papillomas.

Authors:  D J Jones; B P Goorney
Journal:  BMJ       Date:  1992-10-03

2.  European guideline for the management of lymphogranuloma venereum, 2010.

Authors:  H J C de Vries; S A Morré; J A White; H Moi
Journal:  Int J STD AIDS       Date:  2010-08       Impact factor: 1.359

3.  Anorectal syphilis mimicking Crohn's disease.

Authors:  Mesut Yilmaz; Reşat Memisoglu; Selda Aydin; Omur Tabak; Bilgül Mete; Necat Memisoglu; Fehmi Tabak
Journal:  J Infect Chemother       Date:  2011-03-26       Impact factor: 2.211

4.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

Authors:  A G Langenberg; L Corey; R L Ashley; W P Leong; S E Straus
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

5.  2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens.

Authors:  Henry J C de Vries; Adele Zingoni; John A White; Jonathan D C Ross; Alexander Kreuter
Journal:  Int J STD AIDS       Date:  2013-12-18       Impact factor: 1.359

Review 6.  Sexually transmitted and anorectal infectious diseases.

Authors:  Molly M Cone; Charles B Whitlow
Journal:  Gastroenterol Clin North Am       Date:  2013-10-18       Impact factor: 3.806

7.  Lymphogranuloma venereum in Europe, 2003-2008.

Authors:  E J Savage; M J van de Laar; A Gallay; M van der Sande; O Hamouda; A Sasse; S Hoffmann; M Diez; M J Borrego; C M Lowndes; C Ison
Journal:  Euro Surveill       Date:  2009-12-03

Review 8.  Genital herpes.

Authors:  Rachna Gupta; Terri Warren; Anna Wald
Journal:  Lancet       Date:  2007-12-22       Impact factor: 79.321

9.  Persistent high-risk sexual behaviour in men who have sex with men after symptomatic lymphogranuloma venereum proctitis.

Authors:  R R van den Bos; W I van der Meijden
Journal:  Int J STD AIDS       Date:  2007-10       Impact factor: 1.359

10.  Rectal cancer or rectal chancre? Beware of primary syphilis.

Authors:  I Febbraro; G Manetti; P Balestrieri; M Zippi
Journal:  Dig Liver Dis       Date:  2008-03-03       Impact factor: 4.088

View more
  2 in total

Review 1.  [Classical sexually transmitted diseases in the anorectal region].

Authors:  P Spornraft-Ragaller; S Esser
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

Review 2.  [Nonviral sexually transmitted infections-epidemiology, clinical manifestations, diagnostic workup, therapy : Part 3: Treponemes, Gardnerella and trichomonads].

Authors:  P Nenoff; A Manos; I Ehrhard; C Krüger; U Paasch; P Helmbold; W Handrick
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.